AU2016903294A0 - Compositions and methods for autoimmune disease treatment - Google Patents

Compositions and methods for autoimmune disease treatment

Info

Publication number
AU2016903294A0
AU2016903294A0 AU2016903294A AU2016903294A AU2016903294A0 AU 2016903294 A0 AU2016903294 A0 AU 2016903294A0 AU 2016903294 A AU2016903294 A AU 2016903294A AU 2016903294 A AU2016903294 A AU 2016903294A AU 2016903294 A0 AU2016903294 A0 AU 2016903294A0
Authority
AU
Australia
Prior art keywords
compositions
methods
autoimmune disease
disease treatment
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016903294A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash University
Original Assignee
Monash University
Filing date
Publication date
Application filed by Monash University filed Critical Monash University
Publication of AU2016903294A0 publication Critical patent/AU2016903294A0/en
Priority to PCT/US2017/047778 priority Critical patent/WO2018035519A1/en
Priority to AU2017312209A priority patent/AU2017312209A1/en
Priority to US16/326,536 priority patent/US20200246441A1/en
Abandoned legal-status Critical Current

Links

AU2016903294A 2016-08-19 2016-08-19 Compositions and methods for autoimmune disease treatment Abandoned AU2016903294A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/US2017/047778 WO2018035519A1 (en) 2016-08-19 2017-08-21 Compositions and methods for autoimmune disease treatment
AU2017312209A AU2017312209A1 (en) 2016-08-19 2017-08-21 Compositions and methods for autoimmune disease treatment
US16/326,536 US20200246441A1 (en) 2016-08-19 2017-08-21 Compositions and methods for autoimmune disease treatment

Publications (1)

Publication Number Publication Date
AU2016903294A0 true AU2016903294A0 (en) 2016-09-01

Family

ID=

Similar Documents

Publication Publication Date Title
EP3585433A4 (en) Therapeutic compositions and related methods for photoimmunotherapy
EP3373906A4 (en) Compositions and methods for application over skin
EP3099296A4 (en) Isoindoline compositions and methods for treating neurodegenerative disease
EP3601536A4 (en) Treatment methods
EP3408344A4 (en) Well treatment methods and compositions
EP3337465A4 (en) Compositions and methods for use in combination for the treatment and diagnosis of autoimmune diseases
EP3096617A4 (en) Compositions and methods for treating ocular diseases
EP3402533A4 (en) Methods and compositions for the treatment of neurologic disease
EP3373962A4 (en) Compositions and methods for treating autoimmune diseases and cancers
EP3104706A4 (en) Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
EP3182989A4 (en) Methods and compositions for the prevention and treatment of disease
EP3139928A4 (en) Anordrin compositions and methods for treating diseases
EP3310385A4 (en) Methods and compositions for treating fibrotic diseases
EP3442543A4 (en) Compositions and methods for neuralgenesis
EP3134120A4 (en) Compositions and methods for treating cytokine-related disorders
EP3110446A4 (en) Methods and compositions for treating siglec-8 associated diseases
EP3347025A4 (en) Methods and compositions for cancer treatment
EP3117210A4 (en) Compositions and methods for treating eye infections and disease
EP3229793A4 (en) Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease
EP3240577A4 (en) Methods and compositions for treating brain diseases
EP3436467A4 (en) Novel compositions and therapeutic methods
WO2016141334A9 (en) Compositions and methods for diagnosing and treating autoimmune diseases
EP3137907A4 (en) Methods and compositions for the diagnosis and treatment of kawasaki disease
EP3716949A4 (en) Methods of treating autoimmune disease
IL269743A (en) Methods and compositions for treating retina-associated disease using ccr3-inhibitors